alexa Biosimilars In The United States - Update On FDA Implementation And Other Current Issues
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

James C Shehan
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.013
Abstract
Legislation enacted in 2010 as part of the Affordable Care Act established for the first time in the United States a mechanism for approval of biosimilars. But FDA has not approved any biosimilars under the Biologics Price Competition and Innovation Act (BPCIA) in the four years since it was enacted and many policy and procedural issues remain open. This session will explore the current status of biosimilars at FDA and some of the most significant open issues. Included will be what is currently known about FDA standards on biosimilar approval, the heightened standardsfor interchangeability, the BPCIA?s complex patent litigation process, including recent cases such as Sandoz v. Amgen, the provisions regarding exclusivity for reference products, the ongoing debate regarding how biosimilar products should be named, the state of laws and proposed laws in various US states that limit the ability of pharmacists to substitute biosimilars for reference product, and the transitional provisions that take products such as insulin and human growth hormone that are currently regulated as drugs and make them biologics.
Biography
James C Shehan advises healthcare clients on issues such as product development, manufacturing, and promotion, and compliance matters such as internal investigations, government investigations and establishing compliance programs. In the pharmaceutical area, he has particular expertise in product lifecycle strategy, including Hatch-Waxman litigation; the emerging field of biosimilar regulation and policy; and orphan drug regulation and exclusivity. He was Novo Nordisk Inc.?s General Counsel and Corporate Vice President of Legal, Government and Quality for 19 years and has also worked at Pfizer and the US FDA. He has an undergraduate degree from Columbia University and a law degree from Georgetown University Law School.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords